Cargando…

Monitoring processed, mature Human Immunodeficiency Virus type 1 particles immediately following treatment with a protease inhibitor-containing treatment regimen

Protease inhibitors (PIs) block HIV-1 maturation into an infectious virus particle by inhibiting the protease processing of gag and gag-pol precursor proteins. We have used a simple anti-HIV-1 p24 Western blot to monitor the processing of p55(gag )precursor into the mature p24 capsid immediately fol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baird, Heather A, Marozsan, Andre J, Lederman, Michael M, Landay, Alan, Mildvan, Donna, Kuritzkes, Daniel R, Kessler, Harold A, Arts, Eric J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087826/ https://www.ncbi.nlm.nih.gov/pubmed/15826302 http://dx.doi.org/10.1186/1742-6405-2-2

Ejemplares similares

Treatment of HCV NS3/4a Protease Inhibitor Experienced Patients with Sofosbuvir Containing Regimens in an Outpatient Clinic
por: Gilroy, Shelley, et al.
Publicado: (2017)

Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens
por: Budak, Maral, et al.
Publicado: (2023)

Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process
por: Adamson, Catherine S.
Publicado: (2012)

Differential Levels of Soluble Inflammatory Markers by Human Immunodeficiency Virus Controller Status and Demographics
por: Li, Jonathan Z., et al.
Publicado: (2014)

Catfish spine envenomation and bacterial abscess with Proteus and Morganella: a case report
por: Huang, Gary, et al.
Publicado: (2013)

Antibiotic Treatment Failure and Associated Outcomes Among Adult Patients With Community-Acquired Pneumonia in the Outpatient Setting: A Real-world US Insurance Claims Database Study
por: Tillotson, Glenn, et al.
Publicado: (2020)

Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens
por: Marcelin, AG, et al.
Publicado: (2010)

1232 Antibiotic Stewardship for Urinary Tract Infections (UTI): Impact on Therapy and Clinical Outcomes
por: Gill, Veenu, et al.
Publicado: (2014)

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens
por: Younossi, Zobair M., et al.
Publicado: (2016)

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children
por: Larru, Beatriz, et al.
Publicado: (2007)

191. High-Dose Rifampin-containing Regimens for the Treatment of TB Meningitis
por: Ruiz-Bedoya, Camilo A, et al.
Publicado: (2021)

Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort( )
por: Hewison, Catherine, et al.
Publicado: (2022)

A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity
por: Counts, Christopher J., et al.
Publicado: (2015)

The Efficacy and Safety of Sofosbuvir-Containing Regimen in the Treatment of HCV Infection in Patients with Haemoglobinopathy
por: Hussein, N.R.
Publicado: (2017)

Sitafloxacin-Containing Regimen for the Treatment of Refractory Mycobacterium avium Complex Lung Disease
por: Asakura, Takanori, et al.
Publicado: (2019)

Correction to: Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort
Publicado: (2023)

Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens
por: Park, Hae-Young, et al.
Publicado: (2023)

Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency
por: Lum, S. H., et al.
Publicado: (2019)

Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment
por: Baljevic, Muhamed, et al.
Publicado: (2022)

Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
por: Swindells, Susan, et al.
Publicado: (2005)

Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients
por: Stephan, C, et al.
Publicado: (2010)

Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
por: Scherrer, Alexandra U., et al.
Publicado: (2012)

The Immediate Treatment of Sprains
Publicado: (1900)

Real‐world treatment outcomes of sofosbuvir‐based regimens for treatment of chronic hepatitis C with and without human immunodeficiency virus co‐infection
por: Khemnark, Suparat, et al.
Publicado: (2023)

Human Immunodeficiency Virus gag and protease: partners in resistance
por: Fun, Axel, et al.
Publicado: (2012)

Clinical Experience of Patients Receiving Doripenem-Containing Regimens for the Treatment of Healthcare-Associated Infections
por: Chao, Chien-Ming, et al.
Publicado: (2016)

Rescue effects of Lactobacillus-containing bismuth regimens after Helicobacter pylori treatment failure
por: Karbalaei, M., et al.
Publicado: (2021)

Antiretroviral Regimen and Suboptimal Medication Adherence Are Associated With Low-Level Human Immunodeficiency Virus Viremia
por: Konstantopoulos, Christina, et al.
Publicado: (2015)

Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
por: Scherrer, Alexandra U., et al.
Publicado: (2013)

Low level HIV viremia is more frequent under protease-inhibitor containing firstline therapy than under NNRTI-regimens
por: Wiesmann, Frank, et al.
Publicado: (2014)

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon
por: Gambato, Martina, et al.
Publicado: (2016)

Integrase inhibitor-based regimens result in more rapid virologic suppression rates among treatment-naïve human immunodeficiency virus–infected patients compared to non-nucleoside and protease inhibitor–based regimens in a real-world clinical setting: A retrospective cohort study
por: Jacobson, Karen, et al.
Publicado: (2018)

Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa
por: Levison, Julie H., et al.
Publicado: (2012)

Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study
por: Henrich, Timothy J., et al.
Publicado: (2014)

Commentary on the role of treatment-related HIV compensatory mutations on increasing virulence: new discoveries twenty years since the clinical testing of protease inhibitors to block HIV-1 replication
por: Arts, Eric J
Publicado: (2012)

Cobra-Bite: Immediate Treatment
por: Peacocke, J. C. H.
Publicado: (1881)

Burns: Their Immediate Local Treatment
Publicado: (1907)

The Immediate Treatment of Puerperal Sepsis
Publicado: (1909)

The Immediate Treatment of the Uncovered Pulp
por: Jack, Louis
Publicado: (1895)

On the Immediate Treatment of Laceration of the Perinæum
por: Madden, Thomas More
Publicado: (1872)

Cannot write session to /tmp/vufind_sessions/sess_vkqehfhn3pf4ii9v87qfk133hc